RUFY4
gene geneOn this page
Also known as FLJ46536ZFYVE31
Summary
RUFY4 (RUN and FYVE domain containing 4, HGNC:24804) is a protein-coding gene on chromosome 2q35, encoding RUN and FYVE domain-containing protein 4 (Q6ZNE9). ARL8 effector that promotes the coupling of endolysosomes to dynein-dynactin for retrograde transport along microtubules.
Enables phosphatidylinositol-3-phosphate binding activity. Involved in autophagosome assembly; cellular response to interleukin-4; and positive regulation of macroautophagy. Located in autophagosome.
Source: NCBI Gene 285180 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 116 total
- MANE Select transcript:
NM_198483
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24804 |
| Approved symbol | RUFY4 |
| Name | RUN and FYVE domain containing 4 |
| Location | 2q35 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ46536, ZFYVE31 |
| Ensembl gene | ENSG00000188282 |
| Ensembl biotype | protein_coding |
| OMIM | 620994 |
| Entrez | 285180 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 6 protein_coding_CDS_not_defined, 3 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000344321, ENST00000374155, ENST00000457754, ENST00000463618, ENST00000463872, ENST00000465568, ENST00000472496, ENST00000480164, ENST00000495721, ENST00000497857, ENST00000697321
RefSeq mRNA: 1 — MANE Select: NM_198483
NM_198483
Canonical transcript exons
ENST00000697321 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001386201 | 218070753 | 218070859 |
| ENSE00001462614 | 218073816 | 218073885 |
| ENSE00001462616 | 218072779 | 218072885 |
| ENSE00001702335 | 218089952 | 218090584 |
| ENSE00001709916 | 218069253 | 218069348 |
| ENSE00002449418 | 218069481 | 218069558 |
| ENSE00003484646 | 218076427 | 218076533 |
| ENSE00003488695 | 218089252 | 218089362 |
| ENSE00003498596 | 218072374 | 218072499 |
| ENSE00003584110 | 218075093 | 218075740 |
| ENSE00003615421 | 218073243 | 218073386 |
| ENSE00003617790 | 218070500 | 218070651 |
| ENSE00003683022 | 218083110 | 218083256 |
Expression profiles
Bgee: expression breadth ubiquitous, 120 present calls, max score 78.06.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0149 / max 4.7238, expressed in 6 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 25272 | 0.0149 | 6 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.06 | gold quality |
| granulocyte | CL:0000094 | 77.69 | gold quality |
| monocyte | CL:0000576 | 75.87 | gold quality |
| leukocyte | CL:0000738 | 75.17 | gold quality |
| spleen | UBERON:0002106 | 66.62 | gold quality |
| lymph node | UBERON:0000029 | 65.90 | gold quality |
| blood | UBERON:0000178 | 65.56 | gold quality |
| bone marrow | UBERON:0002371 | 65.01 | gold quality |
| bone marrow cell | CL:0002092 | 64.39 | gold quality |
| vermiform appendix | UBERON:0001154 | 64.17 | gold quality |
| gall bladder | UBERON:0002110 | 62.05 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 61.63 | gold quality |
| duodenum | UBERON:0002114 | 61.48 | gold quality |
| tonsil | UBERON:0002372 | 59.73 | gold quality |
| rectum | UBERON:0001052 | 58.72 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 58.34 | gold quality |
| Ammon’s horn | UBERON:0001954 | 57.16 | gold quality |
| prostate gland | UBERON:0002367 | 56.79 | gold quality |
| small intestine | UBERON:0002108 | 55.74 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 55.36 | gold quality |
| right uterine tube | UBERON:0001302 | 54.66 | gold quality |
| urinary bladder | UBERON:0001255 | 54.33 | gold quality |
| amygdala | UBERON:0001876 | 53.66 | gold quality |
| temporal lobe | UBERON:0001871 | 53.60 | gold quality |
| esophagus mucosa | UBERON:0002469 | 52.88 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 52.14 | gold quality |
| right coronary artery | UBERON:0001625 | 51.92 | gold quality |
| left adrenal gland | UBERON:0001234 | 51.60 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 51.44 | gold quality |
| substantia nigra | UBERON:0002038 | 51.34 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.08 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting RUFY4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-4679 | 99.76 | 69.19 | 1229 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-1303 | 99.65 | 69.77 | 1662 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-6733-3P | 99.54 | 67.80 | 1281 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-508-5P | 99.41 | 64.25 | 1248 |
| HSA-MIR-3692-5P | 99.29 | 67.04 | 1421 |
| HSA-MIR-5001-5P | 99.05 | 66.76 | 1972 |
| HSA-MIR-6829-5P | 98.86 | 65.12 | 1480 |
| HSA-MIR-4536-5P | 98.47 | 64.39 | 657 |
| HSA-MIR-6765-3P | 97.83 | 64.59 | 1165 |
| HSA-MIR-5192 | 96.89 | 63.35 | 879 |
| HSA-MIR-3126-5P | 96.87 | 65.83 | 912 |
| HSA-MIR-6875-5P | 96.87 | 65.49 | 958 |
| HSA-MIR-7847-3P | 96.63 | 64.58 | 952 |
| HSA-MIR-4515 | 95.70 | 65.73 | 716 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rufy4 | ENSMUSG00000061815 |
| rattus_norvegicus | Rufy4 | ENSRNOG00000032991 |
Paralogs (1): FYCO1 (ENSG00000163820)
Protein
Protein identifiers
RUN and FYVE domain-containing protein 4 — Q6ZNE9 (reviewed: Q6ZNE9)
All UniProt accessions (2): C9J235, Q6ZNE9
UniProt curated annotations — full annotation on UniProt →
Function. ARL8 effector that promotes the coupling of endolysosomes to dynein-dynactin for retrograde transport along microtubules. Acts by binding both GTP-bound ARL8 and dynein-dynactin. In nonneuronal cells, promotes concentration of endolysosomes in the juxtanuclear area. In hippocampal neurons, drives retrograde transport of endolysosomes from the axon to the soma. Positive regulator of macroautophagy in dendritic cells. Increases autophagic flux, probably by stimulating both autophagosome formation and facilitating tethering with lysosomes. Binds to phosphatidylinositol 3-phosphate (PtdIns3P) through its FYVE-type zinc finger. Positive regulator of osteosclast bone-resorbing activity, possibly by promoting late endosome-lysosome fusion by acting as an adapter protein between RAB7A on late endosomes and LAMP2 on primary lysosomes.
Subunit / interactions. Forms homodimers (via coiled coil domain). Interacts with RAB7A. Forms a ternary complex with RAB7A and LAMP2; the interaction with RAB7A is mediated by RUFY4 (via RUN and coiled coil domains). Interacts with GTP-, but not GDP-bound ARL8A and ARL8B. Interacts with dynactin/DCTN1 and the dynein intermediate chain DYNC1I1/2.
Subcellular location. Cytoplasmic vesicle. Autophagosome. Lysosome.
Domain organisation. The RUN domain and the FYVE-type zinc finger are essential for its function in the positive regulation of macroautophagy.
Induction. Up-regulated by IL4/interleukin-4 in monocyte-derived dendritic cells.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZNE9-2 | 1 | yes |
| Q6ZNE9-3 | 2 |
RefSeq proteins (1): NP_940885* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004012 | Run_dom | Domain |
| IPR011011 | Znf_FYVE_PHD | Homologous_superfamily |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR017455 | Znf_FYVE-rel | Domain |
| IPR037213 | Run_dom_sf | Homologous_superfamily |
| IPR042939 | RUFY4 | Family |
| IPR059036 | RUFY4_dom | Domain |
Pfam: PF02759, PF25366
UniProt features (16 total): binding site 8, splice variant 2, chain 1, domain 1, zinc finger region 1, region of interest 1, coiled-coil region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZNE9-F1 | 68.07 | 0.38 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8): 545; 548; 559; 562; 521; 524; 537; 540
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 105 (showing top):
GOBP_REGULATION_OF_AUTOPHAGY, GOBP_AXO_DENDRITIC_TRANSPORT, GOBP_LYSOSOMAL_TRANSPORT, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, GOBP_VACUOLE_ORGANIZATION, GOBP_RESPONSE_TO_INTERLEUKIN_4, GOBP_RESPONSE_TO_PEPTIDE, GOBP_VESICLE_ORGANIZATION, GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT, GOBP_MEMBRANE_FUSION, GOBP_REGULATION_OF_EXOCYTOSIS, GOBP_VACUOLAR_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, CAGCTG_AP4_Q5, GOBP_MACROAUTOPHAGY
GO Biological Process (8): autophagosome assembly (GO:0000045), positive regulation of macroautophagy (GO:0016239), positive regulation of bone resorption (GO:0045780), positive regulation of exocytosis (GO:0045921), multivesicular body-lysosome fusion (GO:0061763), cellular response to interleukin-4 (GO:0071353), positive regulation of retrograde axon cargo transport (GO:2001019), autophagy (GO:0006914)
GO Molecular Function (5): zinc ion binding (GO:0008270), phosphatidylinositol-3-phosphate binding (GO:0032266), dynactin binding (GO:0034452), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): autophagosome (GO:0005776), endolysosome (GO:0036019), lysosome (GO:0005764), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| Atg12 activating enzyme activity | 1 |
| protein-phosphatidylethanolamide deconjugating activity | 1 |
| Atg12 conjugating enzyme activity | 1 |
| Atg12 ligase activity | 1 |
| organelle assembly | 1 |
| Atg1/ULK1 kinase complex assembly | 1 |
| autophagosome organization | 1 |
| positive regulation of autophagy | 1 |
| macroautophagy | 1 |
| regulation of macroautophagy | 1 |
| regulation of bone resorption | 1 |
| bone resorption | 1 |
| positive regulation of multicellular organismal process | 1 |
| exocytosis | 1 |
| regulation of exocytosis | 1 |
| positive regulation of secretion by cell | 1 |
| vesicle fusion | 1 |
| endosome to lysosome transport via multivesicular body sorting pathway | 1 |
| lysosomal membrane organization | 1 |
| response to interleukin-4 | 1 |
| cellular response to cytokine stimulus | 1 |
| retrograde axonal transport | 1 |
| positive regulation of intracellular transport | 1 |
| regulation of retrograde axon cargo transport | 1 |
| catabolic process | 1 |
| transmembrane transport | 1 |
| process utilizing autophagic mechanism | 1 |
| transition metal ion binding | 1 |
| phosphatidylinositol phosphate binding | 1 |
| cytoskeletal protein binding | 1 |
| binding | 1 |
| cation binding | 1 |
| vacuole | 1 |
| lysosome | 1 |
| endosome | 1 |
| lytic vacuole | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
486 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RUFY4 | RUFY2 | Q8WXA3 | 683 |
| RUFY4 | ARL5B | Q96KC2 | 552 |
| RUFY4 | ZNF142 | P52746 | 532 |
| RUFY4 | TMBIM1 | Q969X1 | 464 |
| RUFY4 | PLEKHM1 | Q9Y4G2 | 444 |
| RUFY4 | STK36 | Q9NRP7 | 432 |
| RUFY4 | TTLL7 | Q6ZT98 | 419 |
| RUFY4 | RUNDC3A | Q59EK9 | 419 |
| RUFY4 | KRTAP10-8 | P60410 | 418 |
| RUFY4 | TMEM44 | Q2T9K0 | 402 |
| RUFY4 | SNRNP48 | Q6IEG0 | 397 |
| RUFY4 | RNF175 | Q8N4F7 | 396 |
| RUFY4 | KRTAP4-1 | Q9BYQ7 | 392 |
| RUFY4 | RAB33A | Q14088 | 380 |
| RUFY4 | NAA30 | Q147X3 | 368 |
IntAct
44 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NDC80 | RUFY4 | psi-mi:“MI:0915”(physical association) | 0.830 |
| RUFY4 | NDC80 | psi-mi:“MI:0915”(physical association) | 0.830 |
| RUFY4 | NDC80 | psi-mi:“MI:0914”(association) | 0.830 |
| RUFY4 | LNX1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| RUFY4 | MAP1LC3C | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDKN2D | RUFY4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RUFY4 | DMWD | psi-mi:“MI:0915”(physical association) | 0.560 |
| RUFY4 | GFAP | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMNA | RUFY4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RUFY4 | NF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSC1 | RUFY4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RUFY4 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | RUFY4 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (21): RUFY4 (Two-hybrid), RUFY4 (Two-hybrid), TRAPPC9 (Affinity Capture-MS), TRAPPC9 (Affinity Capture-MS), RUFY4 (Two-hybrid), RUFY4 (Two-hybrid), RUFY4 (Two-hybrid), RUFY4 (Two-hybrid), MAP1LC3C (Two-hybrid), TRAPPC9 (Affinity Capture-MS), TRAPPC10 (Affinity Capture-MS), TRAPPC6B (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), NDC80 (Affinity Capture-MS)
ESM2 similar proteins: A1L443, A2IDD5, A4IFI1, A6NJZ7, A6NNL0, A6NNM3, A8MT33, B1AL46, D3Z5T1, O95153, Q2M3G4, Q2T9R2, Q3TVI4, Q3TYX8, Q49AM3, Q4KLY2, Q569K6, Q5JTD0, Q5JXC2, Q5SSQ6, Q5SW24, Q5VT03, Q5VZR2, Q6ZNE9, Q7TN08, Q7TNF8, Q7Z591, Q80VJ8, Q810H6, Q811T9, Q86SX3, Q8C963, Q8CB62, Q8CII8, Q8IVF1, Q8IXR5, Q8N0S2, Q8N137, Q8N205, Q8N6L0
Diamond homologs: Q3TYX8, Q6NXD8, Q6ZNE9, Q6ZUT9, Q8VDC1, Q9BQS8, A2RSQ0, A7YDW0, O08576, Q08DX0, Q08E29, Q0V9V7, Q17QK1, Q3B7K9, Q4R7B9, Q59EK9, Q5FVJ0, Q5NVC2, Q5R4V2, Q5R565, Q5R5R4, Q5U3W3, Q6PDC0, Q7L099, Q8BIJ7, Q8R4C2, Q8TEQ0, Q8WXA3, Q96NL0, Q96T51, Q9D394, A8QCE4, A8XJZ8, B0G126, B4JHI7, D3ZVP7, O14964, O17907, O59722, O76054
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
116 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 95 |
| Likely benign | 15 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1898 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:218070648:AGAGG:A | donor_loss | 1.0000 |
| 2:218070649:GAG:G | donor_gain | 1.0000 |
| 2:218070649:GAGGT:G | donor_loss | 1.0000 |
| 2:218070652:GTG:G | donor_loss | 1.0000 |
| 2:218070653:T:G | donor_loss | 1.0000 |
| 2:218072365:T:A | acceptor_gain | 1.0000 |
| 2:218072370:CTAGT:C | acceptor_loss | 1.0000 |
| 2:218072372:A:AG | acceptor_gain | 1.0000 |
| 2:218072372:AGTTT:A | acceptor_gain | 1.0000 |
| 2:218072373:G:GA | acceptor_gain | 1.0000 |
| 2:218072373:GT:G | acceptor_gain | 1.0000 |
| 2:218072373:GTT:G | acceptor_gain | 1.0000 |
| 2:218072373:GTTT:G | acceptor_gain | 1.0000 |
| 2:218072373:GTTTG:G | acceptor_gain | 1.0000 |
| 2:218073385:GA:G | donor_gain | 1.0000 |
| 2:218073387:G:GG | donor_gain | 1.0000 |
| 2:218083257:G:GG | donor_gain | 1.0000 |
| 2:218070652:G:GG | donor_gain | 0.9900 |
| 2:218071830:G:GT | donor_gain | 0.9900 |
| 2:218072361:ATTTT:A | acceptor_gain | 0.9900 |
| 2:218072366:G:A | acceptor_gain | 0.9900 |
| 2:218072499:GGTA:G | donor_loss | 0.9900 |
| 2:218072777:A:AG | acceptor_gain | 0.9900 |
| 2:218072778:G:GG | acceptor_gain | 0.9900 |
| 2:218073239:ACAG:A | acceptor_gain | 0.9900 |
| 2:218073391:G:GG | donor_gain | 0.9900 |
| 2:218073946:T:G | donor_gain | 0.9900 |
| 2:218077583:T:TA | acceptor_gain | 0.9900 |
| 2:218083262:G:GT | donor_gain | 0.9900 |
| 2:218070650:AG:A | donor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000026092 (2:218063616 A>T), RS1000085395 (2:218072321 C>A,T), RS1000120793 (2:218077085 G>A,T), RS1000165553 (2:218047208 C>A), RS1000207270 (2:218088066 T>C), RS1000244996 (2:218067284 C>A,T), RS1000297101 (2:218056342 T>C), RS1000323641 (2:218034501 G>A,T), RS1000372454 (2:218053306 T>A), RS1000447057 (2:218059590 A>G,T), RS1000487610 (2:218077998 G>A), RS1000502820 (2:218050193 G>A), RS1000503540 (2:218048331 A>G), RS1000603992 (2:218055095 A>G), RS1000611208 (2:218081898 CAT>C)
Disease associations
OMIM: gene MIM:620994 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004131_76 | Inflammatory bowel disease | 2.000000e-07 |
| GCST004618_56 | White blood cell count (basophil) | 8.000000e-10 |
| GCST008163_577 | Height | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005090 | basophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.